Antidepressants and anticonvulsants/mood stabilizers in the treatment of autism

Sherie Novotny, Eric Hollander

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Many medications have been used to ameliorate autistic symptoms and behaviors in individuals with autism. Currently, there are no pharmacological treatments with established indications for autism (1). However, psychotropic medications have been used in autistic individuals to target core symptoms, behavioral dyscontrol, treatment of concurrent psychiatric disorders, and management of associated medical conditions such as seizures. Antidepressant medications, particularly serotonin-reuptake inhibitors (SRIs), and anticonvulsant medications are among the medications commonly used for autism spectrum behaviors. The SRIs used include clomipramine (Ananfranil), fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), fluvoxamine (Luvox), and venlafaxine (Effexor). Some of these medications have been studied in an open-label as well as double-blind manner. The results of these studies generally indicate that these medications are efficacious in treating some of the symptoms of individuals with autism spectrum disorder. Anticonvulsants, such as valproic acid and carbamazepine, are used particularly in individuals with comorbid seizure disorder, as well as those with impulsive aggression and affective instability. However, to date no placebo-controlled trials have been published examining the efficacy of these medications. There have, however, been case reports and open-label retrospective studies suggesting the efficacy of these medications in autistic individuals.

Original languageEnglish (US)
Title of host publicationAutism Spectrum Disorders
PublisherCRC Press
Pages231-246
Number of pages16
ISBN (Electronic)9780824755164
ISBN (Print)9780824707156
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Autistic Disorder
Anticonvulsants
Antidepressive Agents
Fluvoxamine
Sertraline
Paroxetine
Fluoxetine
Serotonin Uptake Inhibitors
Clomipramine
Behavioral Symptoms
Carbamazepine
Valproic Acid
Aggression
Psychiatry
Epilepsy
Seizures
Therapeutics
Retrospective Studies
Placebos
Pharmacology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Novotny, S., & Hollander, E. (2003). Antidepressants and anticonvulsants/mood stabilizers in the treatment of autism. In Autism Spectrum Disorders (pp. 231-246). CRC Press.

Antidepressants and anticonvulsants/mood stabilizers in the treatment of autism. / Novotny, Sherie; Hollander, Eric.

Autism Spectrum Disorders. CRC Press, 2003. p. 231-246.

Research output: Chapter in Book/Report/Conference proceedingChapter

Novotny, S & Hollander, E 2003, Antidepressants and anticonvulsants/mood stabilizers in the treatment of autism. in Autism Spectrum Disorders. CRC Press, pp. 231-246.
Novotny S, Hollander E. Antidepressants and anticonvulsants/mood stabilizers in the treatment of autism. In Autism Spectrum Disorders. CRC Press. 2003. p. 231-246
Novotny, Sherie ; Hollander, Eric. / Antidepressants and anticonvulsants/mood stabilizers in the treatment of autism. Autism Spectrum Disorders. CRC Press, 2003. pp. 231-246
@inbook{d7c0c7a7656643418f1c4c052ad1883b,
title = "Antidepressants and anticonvulsants/mood stabilizers in the treatment of autism",
abstract = "Many medications have been used to ameliorate autistic symptoms and behaviors in individuals with autism. Currently, there are no pharmacological treatments with established indications for autism (1). However, psychotropic medications have been used in autistic individuals to target core symptoms, behavioral dyscontrol, treatment of concurrent psychiatric disorders, and management of associated medical conditions such as seizures. Antidepressant medications, particularly serotonin-reuptake inhibitors (SRIs), and anticonvulsant medications are among the medications commonly used for autism spectrum behaviors. The SRIs used include clomipramine (Ananfranil), fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), fluvoxamine (Luvox), and venlafaxine (Effexor). Some of these medications have been studied in an open-label as well as double-blind manner. The results of these studies generally indicate that these medications are efficacious in treating some of the symptoms of individuals with autism spectrum disorder. Anticonvulsants, such as valproic acid and carbamazepine, are used particularly in individuals with comorbid seizure disorder, as well as those with impulsive aggression and affective instability. However, to date no placebo-controlled trials have been published examining the efficacy of these medications. There have, however, been case reports and open-label retrospective studies suggesting the efficacy of these medications in autistic individuals.",
author = "Sherie Novotny and Eric Hollander",
year = "2003",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780824707156",
pages = "231--246",
booktitle = "Autism Spectrum Disorders",
publisher = "CRC Press",

}

TY - CHAP

T1 - Antidepressants and anticonvulsants/mood stabilizers in the treatment of autism

AU - Novotny, Sherie

AU - Hollander, Eric

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Many medications have been used to ameliorate autistic symptoms and behaviors in individuals with autism. Currently, there are no pharmacological treatments with established indications for autism (1). However, psychotropic medications have been used in autistic individuals to target core symptoms, behavioral dyscontrol, treatment of concurrent psychiatric disorders, and management of associated medical conditions such as seizures. Antidepressant medications, particularly serotonin-reuptake inhibitors (SRIs), and anticonvulsant medications are among the medications commonly used for autism spectrum behaviors. The SRIs used include clomipramine (Ananfranil), fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), fluvoxamine (Luvox), and venlafaxine (Effexor). Some of these medications have been studied in an open-label as well as double-blind manner. The results of these studies generally indicate that these medications are efficacious in treating some of the symptoms of individuals with autism spectrum disorder. Anticonvulsants, such as valproic acid and carbamazepine, are used particularly in individuals with comorbid seizure disorder, as well as those with impulsive aggression and affective instability. However, to date no placebo-controlled trials have been published examining the efficacy of these medications. There have, however, been case reports and open-label retrospective studies suggesting the efficacy of these medications in autistic individuals.

AB - Many medications have been used to ameliorate autistic symptoms and behaviors in individuals with autism. Currently, there are no pharmacological treatments with established indications for autism (1). However, psychotropic medications have been used in autistic individuals to target core symptoms, behavioral dyscontrol, treatment of concurrent psychiatric disorders, and management of associated medical conditions such as seizures. Antidepressant medications, particularly serotonin-reuptake inhibitors (SRIs), and anticonvulsant medications are among the medications commonly used for autism spectrum behaviors. The SRIs used include clomipramine (Ananfranil), fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), fluvoxamine (Luvox), and venlafaxine (Effexor). Some of these medications have been studied in an open-label as well as double-blind manner. The results of these studies generally indicate that these medications are efficacious in treating some of the symptoms of individuals with autism spectrum disorder. Anticonvulsants, such as valproic acid and carbamazepine, are used particularly in individuals with comorbid seizure disorder, as well as those with impulsive aggression and affective instability. However, to date no placebo-controlled trials have been published examining the efficacy of these medications. There have, however, been case reports and open-label retrospective studies suggesting the efficacy of these medications in autistic individuals.

UR - http://www.scopus.com/inward/record.url?scp=85056434844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056434844&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85056434844

SN - 9780824707156

SP - 231

EP - 246

BT - Autism Spectrum Disorders

PB - CRC Press

ER -